Hypoxic-ischemic brain injury in the perinatal period is a major cause of morbidity and mortality. Presently, there are no proven effective therapies with which to safeguard the human neonatal brain against this type of injury. Minocycline, a semisynthetic tetracycline, has been shown to be neuropro
Targeting the p53 pathway to protect the neonatal ischemic brain
โ Scribed by Cora H. Nijboer; Cobi J. Heijnen; Michael A. van der Kooij; Jitske Zijlstra; Cindy T.J. van Velthoven; Carsten Culmsee; Frank van Bel; Henrik Hagberg; Annemieke Kavelaars
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 977 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Developing oligodendrocytes (preโOLs) are highly vulnerable to hypoxicโischemic injury and associated excitotoxicity and oxidative stress. 17ฮฒโEstradiol plays an important role in the development and function of the CNS and is neuroprotective. The sudden drop in circulating estrogen aft
## Abstract The powerful tumor suppressor p53 takes charge of a regulatory network to guard over the living cells from harmful effect of different forms of stress and eradicate the tumor cells for normal physiological condition maintenance. However the antitumor function of p53 is often attenuated
Background: Gene therapy of human tumors with adenovirus vectors presents a clinical research challenge and a potential opportunity in cancer therapy. One of the research challenges is that endpoints like tumor reduction, time to recurrence, and survival do not provide information about whether a po
## Abstract We have reported previously the delayed and differential induction of p38ฮฑ and p38ฮฒ mitogenโactivated protein kinases (MAPKs) in microglia and astrocytes, respectively, in brain after transient global ischemia. We report here the sustained induction and activation of p38ฮฑ MAPK in activa